(function(){var loadHandler=window['sl_{3FB6D277-C07C-42BD-BFBD-434A956B3212}'];loadHandler&&loadHandler(56, '<div id="spr0_2866ba96"><div id="spr1_2866ba96" class="kern slide"><img id="img0_2866ba96" src="data/img6.png" width="960px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_2866ba96" class="kern slide"><div id="svg3_2866ba96" style="left:-2.667px;top:55.402px;"><svg width="966" height="10" viewBox="-2.661 -1.333 966 10"><g fill="#203864" stroke="none"><path stroke="#203864" stroke-width="2.667" stroke-linecap="butt" transform="translate(0.005204,-56.734772)" d="M0,61.815 L960,58.068"/></g></svg></div><div id="spr3_2866ba96"><div style="width:0px;"><span id="txt0_2866ba96" data-width="291.791687" style="left:9.6px;top:-0.115px;">A Ravel Revealed</span></div></div><div id="spr4_2866ba96" style="left:15.26px;top:88.887px;"><div style="width:0px;"><span id="txt1_2866ba96" data-width="884.578125" style="left:9.6px;top:2.776px;">Anaemia is severe, with the Hb being very lowβ thalassaemia major (homozygous) thalassaemia that leads to a severe reduction or total</span></div><div style="width:0px;"><span id="txt2_2866ba96" data-width="846.812500" style="left:9.6px;top:21.976px;">lack of synthesis of β globin chains. Consequently, there is a marked reduction or total failure to synthesize hemoglobin A. There is</span></div><div style="width:0px;"><span id="txt3_2866ba96" data-width="873.328125" style="left:9.6px;top:41.176px;">marked erythroid hyperplasia306 Chapter 8and ineffective haemopoiesis resulting from damage to developing erythroblasts by excess</span></div><div style="width:0px;"><span id="txt4_2866ba96" data-width="871.242188" style="left:9.6px;top:60.376px;">free α chains. Clinical features are severe anemia, hepatomegaly, splenomegaly and expansion of marrow‐containing bones leading to</span></div><div style="width:0px;"><span id="txt5_2866ba96" data-width="884.320313" style="left:9.6px;top:79.576px;">frontal bossing of the skull and deformity of the jaw bones. There is significant growth retardation. Treatment of β thalassemia major by</span></div><div style="width:0px;"><span id="txt6_2866ba96" data-width="858.796875" style="left:9.6px;top:98.776px;">blood transfusion ameliorates many of the clinicopathological features seen in the untreated patient but, in the absence of effective</span></div><div style="width:0px;"><span id="txt7_2866ba96" data-width="574.265625" style="left:9.6px;top:117.976px;">chelation therapy, leads to iron overload, resultant organ damage and premature death.</span></div></div><div id="spr5_2866ba96" style="left:3.682px;top:65.628px;"><div style="width:0px;"><span id="txt8_2866ba96" data-width="69.772133" style="left:10.031px;top:2.439px;">Patient 1</span></div></div></div></div>', '{"s":[]}');})();